Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptor, erbB-2 | 3 | 2024 | 2601 | 0.960 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 4 | 2024 | 5394 | 0.780 |
Why?
|
Lung Neoplasms | 5 | 2024 | 13500 | 0.780 |
Why?
|
Yellow Nail Syndrome | 1 | 2018 | 2 | 0.640 |
Why?
|
Pleurodesis | 1 | 2018 | 49 | 0.610 |
Why?
|
Chylothorax | 1 | 2018 | 83 | 0.580 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2024 | 2428 | 0.580 |
Why?
|
Myocarditis | 2 | 2022 | 802 | 0.530 |
Why?
|
Problem-Based Learning | 1 | 2019 | 360 | 0.490 |
Why?
|
Proto-Oncogene Proteins | 2 | 2024 | 4525 | 0.470 |
Why?
|
Calorimetry, Indirect | 1 | 2014 | 177 | 0.440 |
Why?
|
Cardiovascular System | 1 | 2020 | 841 | 0.420 |
Why?
|
Clinical Competence | 2 | 2019 | 4857 | 0.380 |
Why?
|
Teaching | 1 | 2019 | 1171 | 0.370 |
Why?
|
Actigraphy | 1 | 2014 | 527 | 0.340 |
Why?
|
Mutation | 3 | 2024 | 30214 | 0.340 |
Why?
|
Antineoplastic Agents | 5 | 2024 | 13658 | 0.330 |
Why?
|
Education, Medical, Undergraduate | 1 | 2019 | 1085 | 0.330 |
Why?
|
Coronary Artery Bypass | 1 | 2018 | 2191 | 0.320 |
Why?
|
Neoplasms | 5 | 2024 | 22369 | 0.290 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2024 | 11874 | 0.270 |
Why?
|
Electronic Health Records | 1 | 2024 | 4884 | 0.260 |
Why?
|
Monitoring, Physiologic | 1 | 2014 | 1798 | 0.260 |
Why?
|
Students, Medical | 1 | 2019 | 1963 | 0.250 |
Why?
|
Hypertension | 1 | 2024 | 8616 | 0.230 |
Why?
|
Energy Metabolism | 2 | 2017 | 2908 | 0.220 |
Why?
|
Physician-Patient Relations | 1 | 2016 | 3269 | 0.200 |
Why?
|
Breast Neoplasms | 7 | 2017 | 21209 | 0.150 |
Why?
|
Talc | 1 | 2018 | 48 | 0.150 |
Why?
|
Fatigue | 2 | 2017 | 1557 | 0.150 |
Why?
|
Thoracic Duct | 1 | 2018 | 71 | 0.150 |
Why?
|
Chest Tubes | 1 | 2018 | 153 | 0.150 |
Why?
|
Lymphography | 1 | 2018 | 189 | 0.150 |
Why?
|
Databases, Genetic | 1 | 2024 | 1758 | 0.140 |
Why?
|
Doxycycline | 1 | 2018 | 348 | 0.130 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2024 | 1608 | 0.130 |
Why?
|
Faculty | 1 | 2019 | 383 | 0.120 |
Why?
|
Neoadjuvant Therapy | 3 | 2017 | 2903 | 0.120 |
Why?
|
Blood Pressure | 2 | 2024 | 8539 | 0.120 |
Why?
|
Humans | 22 | 2024 | 767998 | 0.110 |
Why?
|
Neoplasm Metastasis | 1 | 2024 | 4904 | 0.110 |
Why?
|
Schools, Medical | 1 | 2019 | 882 | 0.100 |
Why?
|
Cyclophosphamide | 2 | 2017 | 2227 | 0.100 |
Why?
|
Survival Rate | 2 | 2024 | 12827 | 0.090 |
Why?
|
Doxorubicin | 2 | 2017 | 2234 | 0.090 |
Why?
|
Retrospective Studies | 3 | 2024 | 81748 | 0.090 |
Why?
|
Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2009 | 29 | 0.080 |
Why?
|
Prevalence | 2 | 2024 | 15867 | 0.080 |
Why?
|
Middle Aged | 8 | 2024 | 223422 | 0.080 |
Why?
|
Treatment Outcome | 3 | 2024 | 65360 | 0.080 |
Why?
|
Databases, Factual | 1 | 2024 | 8082 | 0.070 |
Why?
|
Neoplasm Staging | 4 | 2017 | 11221 | 0.070 |
Why?
|
Heart Diseases | 1 | 2020 | 2819 | 0.070 |
Why?
|
United States | 2 | 2024 | 73033 | 0.060 |
Why?
|
Neural Stem Cells | 1 | 2013 | 895 | 0.060 |
Why?
|
Curriculum | 1 | 2019 | 3783 | 0.060 |
Why?
|
Aged | 4 | 2024 | 171453 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 5694 | 0.060 |
Why?
|
Protein Isoforms | 1 | 2009 | 1715 | 0.060 |
Why?
|
Motor Activity | 1 | 2014 | 2711 | 0.060 |
Why?
|
Education, Medical | 1 | 2016 | 1742 | 0.060 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3115 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3238 | 0.050 |
Why?
|
Female | 10 | 2024 | 397102 | 0.050 |
Why?
|
Off-Label Use | 1 | 2024 | 185 | 0.050 |
Why?
|
Hematologic Neoplasms | 1 | 2013 | 1907 | 0.050 |
Why?
|
Male | 4 | 2024 | 364638 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 7469 | 0.040 |
Why?
|
Risk Factors | 2 | 2024 | 74938 | 0.040 |
Why?
|
Anxiety | 1 | 2013 | 4672 | 0.040 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 325 | 0.040 |
Why?
|
Stress, Psychological | 1 | 2013 | 4529 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2017 | 3553 | 0.040 |
Why?
|
Depression | 2 | 2017 | 8231 | 0.040 |
Why?
|
Chemokine CCL3 | 1 | 2017 | 85 | 0.030 |
Why?
|
Chemokine CCL11 | 1 | 2017 | 128 | 0.030 |
Why?
|
Trail Making Test | 1 | 2017 | 57 | 0.030 |
Why?
|
Prospective Studies | 2 | 2019 | 54921 | 0.030 |
Why?
|
Breast Diseases | 1 | 1999 | 442 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2018 | 15831 | 0.030 |
Why?
|
Cytodiagnosis | 1 | 1999 | 450 | 0.030 |
Why?
|
Epitopes | 1 | 2022 | 2526 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1854 | 0.030 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2017 | 299 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 1999 | 1622 | 0.030 |
Why?
|
Chemokine CCL2 | 1 | 2017 | 605 | 0.030 |
Why?
|
Interleukin-12 | 1 | 2017 | 577 | 0.030 |
Why?
|
Bone Morphogenetic Protein 4 | 1 | 2013 | 163 | 0.030 |
Why?
|
Waist Circumference | 1 | 2016 | 935 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2009 | 9253 | 0.020 |
Why?
|
Premenopause | 1 | 2016 | 1039 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2013 | 9116 | 0.020 |
Why?
|
SOXB1 Transcription Factors | 1 | 2013 | 283 | 0.020 |
Why?
|
Myocytes, Cardiac | 1 | 2020 | 1681 | 0.020 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2013 | 344 | 0.020 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2013 | 563 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2016 | 1820 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2013 | 1340 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2009 | 294 | 0.020 |
Why?
|
California | 1 | 2012 | 1439 | 0.020 |
Why?
|
Triglycerides | 1 | 2016 | 2463 | 0.020 |
Why?
|
Postmenopause | 1 | 2016 | 2518 | 0.020 |
Why?
|
Linear Models | 1 | 2017 | 5883 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4748 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 14785 | 0.020 |
Why?
|
Adult | 3 | 2017 | 223577 | 0.020 |
Why?
|
Survivors | 1 | 2016 | 2381 | 0.020 |
Why?
|
Self Report | 1 | 2017 | 3773 | 0.020 |
Why?
|
Lipids | 1 | 2016 | 3342 | 0.020 |
Why?
|
Cytokines | 1 | 2020 | 7453 | 0.010 |
Why?
|
Cell Line, Tumor | 2 | 2013 | 17128 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2016 | 3858 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2012 | 6225 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2017 | 7140 | 0.010 |
Why?
|
Animals | 3 | 2022 | 169225 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2016 | 3986 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4576 | 0.010 |
Why?
|
Blood Glucose | 1 | 2016 | 6429 | 0.010 |
Why?
|
Mice | 2 | 2022 | 82024 | 0.010 |
Why?
|
Sleep | 1 | 2017 | 4817 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2013 | 4414 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8750 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10629 | 0.010 |
Why?
|
Palpation | 1 | 1999 | 166 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12075 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12536 | 0.010 |
Why?
|
Prognosis | 1 | 2016 | 29984 | 0.010 |
Why?
|
Staining and Labeling | 1 | 1999 | 1080 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2013 | 11666 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39340 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2009 | 5335 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2013 | 59600 | 0.000 |
Why?
|
Adolescent | 1 | 2013 | 89154 | 0.000 |
Why?
|
Time Factors | 1 | 1999 | 40210 | 0.000 |
Why?
|
Concepts
(134)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(3)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_